Plain-English translation of NCT07360938 on ClinicalTrials.gov ↗ · Source last updated · Translation generated ·
Researchers know that inflammation in the body can change how medications work and are processed. This study is collecting blood samples from people with three specific conditions—type 2 diabetes, end-stage kidney disease, and inflammatory bowel disease—to understand exactly how inflammation affects medication processing. By studying this in people with different levels of disease severity, scientists hope to predict and prevent dangerous drug interactions.
People with chronic inflammatory diseases often take multiple medications, but inflammation can interfere with how the body breaks down and uses these drugs, potentially causing harmful side effects. This research aims to understand this problem so doctors can better protect patients from dangerous medication interactions.
You likely qualify if…
You likely don't qualify if…
As a participant, you would donate blood samples and have your inflammation levels measured using standard tests already used to monitor your condition (like hemoglobin A1C for diabetes or C-reactive protein for inflammatory bowel disease). Researchers will use these samples and measurements to study how inflammation in your body affects how medications are processed, and may follow your health status over time to track changes in inflammation severity.
AI-generated summary from trial data · Jun 18, 2026 · Not medical advice
United States